149 related articles for article (PubMed ID: 11853926)
1. The enhancing effect of nasal absorption of FITC-dextran 4,400 by beta-sitosterol beta-D-glucoside in rabbits.
Nakamura K; Maitani Y; Takayama K
J Control Release; 2002 Feb; 79(1-3):147-55. PubMed ID: 11853926
[TBL] [Abstract][Full Text] [Related]
2. Regional intestinal absorption of FITC-dextran 4,400 with nanoparticles based on beta-sitosterol beta-D-glucoside in rats.
Nakamura K; Takayama K; Nagai T; Maitani Y
J Pharm Sci; 2003 Feb; 92(2):311-8. PubMed ID: 12532381
[TBL] [Abstract][Full Text] [Related]
3. The enhancing effect of soybean-derived sterylglucoside and beta-sitosterol beta-D-glucoside on nasal absorption in rabbits.
Maitani Y; Nakamura K; Suenaga H; Kamata K; Takayama K; Nagai T
Int J Pharm; 2000 Apr; 200(1):17-26. PubMed ID: 10845682
[TBL] [Abstract][Full Text] [Related]
4. Screening of cationic compounds as an absorption enhancer for nasal drug delivery.
Natsume H; Iwata S; Ohtake K; Miyamoto M; Yamaguchi M; Hosoya K; Kobayashi D; Sugibayashi K; Morimoto Y
Int J Pharm; 1999 Aug; 185(1):1-12. PubMed ID: 10425360
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of enhancers to increase nasal absorption using Ussing chamber technique.
Hosoya K; Kubo H; Natsume H; Sugibayashi K; Morimoto Y
Biol Pharm Bull; 1994 Feb; 17(2):316-22. PubMed ID: 7515747
[TBL] [Abstract][Full Text] [Related]
6. Effect of sodium taurodihydrofusidate on nasal drug delivery: differences in its concentration and penetrant molecular weight.
Hosoya K; Kubo H; Akutsu T; Natsume H; Sugibayashi K; Morimoto Y
Arch Pharm Res; 1994 Apr; 17(2):57-9. PubMed ID: 10319131
[TBL] [Abstract][Full Text] [Related]
7. Confocal laser scanning microscopic visualization of the transport of dextrans after nasal administration to rats: effects of absorption enhancers.
Marttin E; Verhoef JC; Cullander C; Romeijn SG; Nagelkerke JF; Merkus FW
Pharm Res; 1997 May; 14(5):631-7. PubMed ID: 9165535
[TBL] [Abstract][Full Text] [Related]
8. Analysis of transient and reversible effects of poly-L-arginine on the in vivo nasal absorption of FITC-dextran in rats.
Ohtake K; Natsume H; Ueda H; Morimoto Y
J Control Release; 2002 Aug; 82(2-3):263-75. PubMed ID: 12175742
[TBL] [Abstract][Full Text] [Related]
9. Influence of formulation viscosity on drug absorption following nasal application in rats.
Furubayashi T; Inoue D; Kamaguchi A; Higashi Y; Sakane T
Drug Metab Pharmacokinet; 2007 Jun; 22(3):206-11. PubMed ID: 17603222
[TBL] [Abstract][Full Text] [Related]
10. Aminated gelatin as a nasal absorption enhancer for peptide drugs: evaluation of absorption enhancing effect and nasal mucosa perturbation in rats.
Wang J; Sakai S; Deguchi Y; Bi D; Tabata Y; Morimoto K
J Pharm Pharmacol; 2002 Feb; 54(2):181-8. PubMed ID: 11848281
[TBL] [Abstract][Full Text] [Related]
11. Improved nasal bioavailability of FITC-dextran (Mw 4300) from mucoadhesive microspheres in rabbits.
El-Shafy MA; Kellaway IW; Taylor G; Dickinson PA
J Drug Target; 2000; 7(5):355-61. PubMed ID: 10721797
[TBL] [Abstract][Full Text] [Related]
12. Effects of polyamidoamine (PAMAM) dendrimers on the nasal absorption of poorly absorbable drugs in rats.
Dong Z; Katsumi H; Sakane T; Yamamoto A
Int J Pharm; 2010 Jun; 393(1-2):244-52. PubMed ID: 20417700
[TBL] [Abstract][Full Text] [Related]
13. The structural barrier of absorptive mucosae: site difference of the permeability of fluorescein isothiocyanate-labelled dextran in rabbits.
Hosoya K; Kubo H; Natsume H; Sugibayashi K; Morimoto Y; Yamashita S
Biopharm Drug Dispos; 1993 Nov; 14(8):685-95. PubMed ID: 7508274
[TBL] [Abstract][Full Text] [Related]
14. Nasal insulin delivery in rabbits using soybean-derived sterylglucoside and sterol mixtures as novel enhancers in suspension dosage forms.
Ando T; Maitani Y; Yamamoto T; Takayama K; Nagai T
Biol Pharm Bull; 1998 Aug; 21(8):862-5. PubMed ID: 9743258
[TBL] [Abstract][Full Text] [Related]
15. Effect of poly-L-arginine on the nasal absorption of FITC-dextran of different molecular weights and recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rats.
Miyamoto M; Natsume H; Satoh I; Ohtake K; Yamaguchi M; Kobayashi D; Sugibayashi K; Morimoto Y
Int J Pharm; 2001 Sep; 226(1-2):127-38. PubMed ID: 11532576
[TBL] [Abstract][Full Text] [Related]
16. Permeation-enhancing effects of chitosan formulations on recombinant hirudin-2 by nasal delivery in vitro and in vivo.
Zhang YJ; Ma CH; Lu WL; Zhang X; Wang XL; Sun JN; Zhang Q
Acta Pharmacol Sin; 2005 Nov; 26(11):1402-8. PubMed ID: 16225765
[TBL] [Abstract][Full Text] [Related]
17. Improved nasal absorption of drugs using poly-L-arginine: effects of concentration and molecular weight of poly-L-arginine on the nasal absorption of fluorescein isothiocyanate-dextran in rats.
Miyamoto M; Natsume H; Iwata S; Ohtake K; Yamaguchi M; Kobayashi D; Sugibayashi K; Yamashina M; Morimoto Y
Eur J Pharm Biopharm; 2001 Jul; 52(1):21-30. PubMed ID: 11438420
[TBL] [Abstract][Full Text] [Related]
18. N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.
Thanou M; Henderson S; Kydonieus A; Elson C
J Control Release; 2007 Feb; 117(2):171-8. PubMed ID: 17184870
[TBL] [Abstract][Full Text] [Related]
19. Cultivation of RPMI 2650 cells as an in-vitro model for human transmucosal nasal drug absorption studies: optimization of selected culture conditions.
Reichl S; Becker K
J Pharm Pharmacol; 2012 Nov; 64(11):1621-30. PubMed ID: 23058049
[TBL] [Abstract][Full Text] [Related]
20. Mucosal drug delivery using cellulose derivatives as a functional polymer.
Suzuki Y; Makino Y
J Control Release; 1999 Nov; 62(1-2):101-7. PubMed ID: 10518641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
